title: Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia.
abstract: BACKGROUND
  Expression of messenger RNA (mRNA) for the gamma-aminobutyric acid (GABA)-synthesizing enzyme, glutamic acid decarboxylase (GAD), in the prefrontal cortex and the number of GABAergic neurons in the hippocampus are reduced in schizophrenia and bipolar disorder. We tested the hypothesis that the expression of the 2 isoforms, one 65 kd (GAD(65)) and the other 67 kd (GAD(67)), is differentially affected in the hippocampus in schizophrenia and bipolar disorder.
  
  
  METHODS
  Hippocampal sections from 15 subjects in 3 groups (control subjects and subjects with schizophrenia and bipolar disorder) were studied using an in situ hybridization protocol with sulfur 35-labeled complementary riboprobes for GAD(65) and GAD(67) mRNA. Emulsion-dipped slides were analyzed for the density of GAD mRNA-positive neurons in 4 sectors of the hippocampus and for the cellular expression level of both GAD mRNAs.
  
  
  RESULTS
  The density of GAD(65) and GAD(67) mRNA-positive neurons was decreased by 45% and 43%, respectively, in subjects with bipolar disorder, but only 14% and 4%, respectively, in subjects with schizophrenia. The decreased density of GAD(65) mRNA-positive neurons in subjects with bipolar disorder was significant in sectors CA2/3 and dentate gyrus, and that of GAD(67) mRNA-positive neurons was significant in CA4, but not other hippocampal sectors. Cellular GAD(65) mRNA expression was significantly decreased in subjects with bipolar disorder, particularly in CA4, but not in schizophrenic subjects. Cellular GAD(67) mRNA expression was normal in both groups.
  
  
  CONCLUSIONS
  We have found a region-specific deficit of GAD(65) and GAD(67) mRNA expression in bipolar disorder.
authors.affiliation: Laboratory of Structural Neuroscience, McLean Hospital, Belmont, MA 02429, USA.
authors.forename: Stephan
authors.initials: S
authors.lastname: Heckers
authors.forename: David
authors.initials: D
authors.lastname: Stone
authors.forename: John
authors.initials: J
authors.lastname: Walsh
authors.forename: John
authors.initials: J
authors.lastname: Shick
authors.forename: Pamposh
authors.initials: P
authors.lastname: Koul
authors.forename: Francine M
authors.initials: FM
authors.lastname: Benes
mesh_terms: D000328:Adult; D000368:Aged; D001714:Bipolar Disorder / Q000175:diagnosis / Q000201:enzymology* / Q000378:metabolism; D003937:Diagnosis, Differential; D005260:Female; D005968:Glutamate Decarboxylase / Q000378:metabolism*; D006624:Hippocampus / Q000166:cytology / Q000201:enzymology / Q000378:metabolism*; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009474:Neurons / Q000201:enzymology / Q000378:metabolism; D010446:Peptide Fragments / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D012559:Schizophrenia / Q000175:diagnosis / Q000201:enzymology* / Q000378:metabolism
chemical_list: D007527:Isoenzymes; D010446:Peptide Fragments; D012333:RNA, Messenger; D005968:Glutamate Decarboxylase; C402565:glutamate decarboxylase 1